Redox signaling-governed drug-tolerant persister cancer cell: a key spark of treatment failure

Signal Transduct Target Ther. 2022 Mar 17;7(1):89. doi: 10.1038/s41392-022-00940-0.

Liwu Fu¹, Zhe-Sheng Chen^{2

3}

¹ State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute, Cancer Center, Sun Yat-Sen University, Guangzhou, 510060, China. fulw@mail.sysu.edu.cn.
² Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 11439, USA. chenz@stjohns.edu.
³ Institute for Biotechnology, St. John's University, Queens, NY, 11439, USA. chenz@stjohns.edu.

No abstract available

Publication types